Genmab — April 2023

[gentogen]

We reported that 4 patients with refractory acquired hemophilia A were treated with daratumumab.. All 4 patients achieved varying degrees of remission after daratumumab treatment.. Daratumumab provides a new option for the treatment of refractory acquired hemophilia with good efficacy and safety
.

[gentogen]

ScienceDirect

(www.sciencedirect.com)

[Bulder]

Det er jo herligt. Så kan mim8 og dara supplere hinanden, i tilfælde af resistens.

[Bulder]

Der skulle komme mim8 data til næste år.

[Bulder]

… fra fase 3 studiet.

[gentogen]

Det har åbenbart været kendt længe. For eksempel her: https://onlinelibrary.wiley.com/doi/10.1111/hae.14118

[gentogen]

Eller her: https://hemophilianewstoday.com/news/cancer-therapy-daratumumab-can-effectively-lower-inhibitors-hemophilia-a-case-series/

[E_L]

Horizon Therapeutics plc Announces Positive Topline Data from TEPEZZA (teprotumumab-trbw) Phase 4 Clinical Trial in Patients with Chronic/Low Clinical Activity Score (CAS) Thyroid Eye Disease (TED) https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-announces-positive-topline-data

[Bulder]

Do we have an estimate for Tepezza sales fy 2023?

[E_L]

i can't find anything in my notes, can't remember them giving guidance.. we may get less information once Amgen is in control..

[E_L]

small new trial for Daratumumab in Non-small Cell Lung Cancer With STK11/LKB1 Mutation (not by JNJ) https://clinicaltrials.gov/ct2/show/NCT05807048

[MarsFars]

God aften ?

[Helge_LarsenPI-redaktør]

Investeringspodcasten: Fokus på C25 og sidste udkald for SAS
https://www.proinvestor.com/boards/111969

[Helge_LarsenPI-redaktør]

Genmab sidst i udsendelsen.

[Helge_LarsenPI-redaktør]

Godmorgen

[transalp]

Go morgen..

[bibob]

God morgen

[E_L]

Successful treatment with subcutaneous ofatumumab in an adolescent patient with refractory myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease (MOGAD) https://www.sciencedirect.com/science/article/pii/S2405650223000199?via%3Dihub

[Teller]

I forhold til retssagen, hvor meget vurderes der at være lagt ind i kursen pt? i begge retninget?

[StockBull]

Den lave PE værdi / kurs indikere markedet har indregnet at Genmab taber voldgiften. Derfor en pæn optur hvis Genmab mod markedets forventning vinder sagen.